Sophia Genetics, a specialist in data-driven medicine, has raised $13.75m in its series B. The round was led by Invoke Capital, which was joined by Swisscom and Endeavour Vision.
Apart from the cash injection, Sophia gains access to Invoke’s portfolio company Genalys, which uses big data mathematics to analyse genomic information.
Spun out of the Federal Institute of Technology Lausanne in 2011, the Swiss company’s technology makes it possible to diagnose genetic diseases and the DNA of cancer tumours through a combination of next generation sequencing and highly accurate and scalable predictive algorithms. It is hoped that now that Sophia and Genalys have access to each other’s expertise, the technology can be improved even further.
Sophia Genetics previously raised $2.8m in 2013 from undisclosed investors. The company is ahead of its competition in that it is already fully compliant with European data privacy laws. Its technology is…
Invoke Capital leads Sophia’s series B
Jul 9, 2014 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
University of Notre Dame tries new, supersized approach to creating spinouts
University of Notre Dame tries new, supersized approach to creating spinouts
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
How Basel supercharged its spinout rate
How Basel supercharged its spinout rate
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
May 9, 2024
Online
Events
Webinar: CVCs and the art of the follow-on
May 8, 2024
Online
Online
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg